Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Sandip Basu

Showing results (461-470 of 520) with videos related to

Pageof 52
Sort By:
Hellenic Journal of Nuclear Medicine|August 14, 2009
A pilot study of changes in (18)F-FDG uptake, calcification and global metabolic activity of the aorta with agingGonca G Bural, Drew A Torigian, Elias Botvinick, et al.
Molecular Imaging and Biology|December 17, 2009
Degree of tumor FDG uptake correlates with proliferation index in triple negative breast cancerJulia Tchou, Seema S Sonnad, Meredith R Bergey, et al.
Journal of Nuclear Medicine Technology|November 11, 2018
Biodistribution and Dosimetry of Indigenously Produced <sup>131</sup>I-Rituximab in B-Cell Lymphoma: Pilot Study Estimating Patient-Specific Dose Comparing 2 Different Dosimetric MethodsAadil Adnan, Kamal Deep, Mythilli Kameswaran, et al.
Neuroendocrinology|December 3, 2024
Systemic Cancer Hallmarks as Novel Markers Associated with Progression-Free Survival in Gastroenteropancreatic Neuroendocrine Tumor Patients Undergoing Peptide Receptor Radionuclide TherapyMahesh Kumar Padwal, Rahul Vithalrao Parghane, Avik Chakraborty, et al.
Seminars in Nuclear Medicine|April 10, 2007
Novel quantitative techniques for assessing regional and global function and structure based on modern imaging modalities: implications for normal variation, aging and diseased statesSandip Basu, Habib Zaidi, Mohamed Houseni, et al.
Nuclear Medicine Communications|September 16, 2021
Prospective evaluation of organ-specific dose and lesional doses following therapeutic [177Lu]Lu-EDTMP administration in patients with multiple skeletal metastases and its correlation with clinical hematological toxicityKamaldeep, Pradeep Thapa, Gaurav Wanage, et al.
The British Journal of Radiology|October 11, 2019
Therapeutic efficacy, prognostic variables and clinical outcome of <sup>177</sup>Lu-PSMA-617 PRLT in progressive mCRPC following multiple lines of treatment: prognostic implications of high FDG uptake on dual tracer PET-CT vis-à-vis Gleason score in such cohortSonam Suman, Rahul V Parghane, Amit Joshi, et al.
Nuclear Medicine Communications|November 29, 2013
Evaluation of the (14)C-urea breath test using indigenously produced (14)C-urea capsules and a modified technique for trapping exhaled breath: a pilot studyBijaynath P Tiwari, Srinivas Nistala, Sanjay P Patil, et al.
Journal of Neuroendocrinology|November 14, 2024
Developing a peripheral blood RNA-seq based NETseq ensemble classifier: A potential novel tool for non-invasive detection and treatment response assessment in neuroendocrine tumor patients receiving <sup>177</sup>Lu-DOTATATE PRRTMahesh K Padwal, Rahul V Parghane, Avik Chakraborty, et al.
PET Clinics|June 9, 2015
The Basic Principles of FDG-PET/CT ImagingSandip Basu, Søren Hess, Poul-Erik Nielsen Braad, et al.
Pageof 52

Showing results (461-470 of 520) with videos related to

Sort By:
Pageof 52
Hellenic Journal of Nuclear Medicine|August 14, 2009
A pilot study of changes in (18)F-FDG uptake, calcification and global metabolic activity of the aorta with agingGonca G Bural, Drew A Torigian, Elias Botvinick, et al.
Molecular Imaging and Biology|December 17, 2009
Degree of tumor FDG uptake correlates with proliferation index in triple negative breast cancerJulia Tchou, Seema S Sonnad, Meredith R Bergey, et al.
Journal of Nuclear Medicine Technology|November 11, 2018
Biodistribution and Dosimetry of Indigenously Produced <sup>131</sup>I-Rituximab in B-Cell Lymphoma: Pilot Study Estimating Patient-Specific Dose Comparing 2 Different Dosimetric MethodsAadil Adnan, Kamal Deep, Mythilli Kameswaran, et al.
Neuroendocrinology|December 3, 2024
Systemic Cancer Hallmarks as Novel Markers Associated with Progression-Free Survival in Gastroenteropancreatic Neuroendocrine Tumor Patients Undergoing Peptide Receptor Radionuclide TherapyMahesh Kumar Padwal, Rahul Vithalrao Parghane, Avik Chakraborty, et al.
Seminars in Nuclear Medicine|April 10, 2007
Novel quantitative techniques for assessing regional and global function and structure based on modern imaging modalities: implications for normal variation, aging and diseased statesSandip Basu, Habib Zaidi, Mohamed Houseni, et al.
Nuclear Medicine Communications|September 16, 2021
Prospective evaluation of organ-specific dose and lesional doses following therapeutic [177Lu]Lu-EDTMP administration in patients with multiple skeletal metastases and its correlation with clinical hematological toxicityKamaldeep, Pradeep Thapa, Gaurav Wanage, et al.
The British Journal of Radiology|October 11, 2019
Therapeutic efficacy, prognostic variables and clinical outcome of <sup>177</sup>Lu-PSMA-617 PRLT in progressive mCRPC following multiple lines of treatment: prognostic implications of high FDG uptake on dual tracer PET-CT vis-à-vis Gleason score in such cohortSonam Suman, Rahul V Parghane, Amit Joshi, et al.
Nuclear Medicine Communications|November 29, 2013
Evaluation of the (14)C-urea breath test using indigenously produced (14)C-urea capsules and a modified technique for trapping exhaled breath: a pilot studyBijaynath P Tiwari, Srinivas Nistala, Sanjay P Patil, et al.
Journal of Neuroendocrinology|November 14, 2024
Developing a peripheral blood RNA-seq based NETseq ensemble classifier: A potential novel tool for non-invasive detection and treatment response assessment in neuroendocrine tumor patients receiving <sup>177</sup>Lu-DOTATATE PRRTMahesh K Padwal, Rahul V Parghane, Avik Chakraborty, et al.
PET Clinics|June 9, 2015
The Basic Principles of FDG-PET/CT ImagingSandip Basu, Søren Hess, Poul-Erik Nielsen Braad, et al.
Pageof 52